Novartis: Data Shows Arzerra, Chlorambucil Improved Median PFS In CLL Patients

Novartis AG (NVS) said that last stage data published in The Lancet showed that treatment with Arzerra or ofatumumab plus chlorambucil, a chemotherapy, resulted in a statistically significant improvement in progression free survival or PFS versus chlorambucil alone in treatment-naïve patients with chronic lymphocytic leukemia or CLL for whom fludarabine-based therapy was considered inappropriate, mainly due to advanced age or the presence of comorbidities.

CLL, the most commonly diagnosed adult leukemia in Western countries, accounts for approximately 1 in 4 cases of all leukemia. The average age at the time of diagnosis is approximately 71 years, and the majority of patients with CLL have at least one comorbidity such as hypertension, diabetes, heart disease or COPD.

The primary endpoint of the study was PFS according to the International Workshop for Chronic Lymphocytic Leukaemia (iwCLL) updated 2008 National Cancer Institute-sponsored Working Group (NCIWG) guidelines. In this clinical study, median PFS was improved by 71% in the group receiving ofatumumab plus chlorambucil compared to the chlorambucil alone group (22.4 months vs 13.1 months, respectively; HR 0.57 [95% CI 0.45, 0.72]; p<0.0001). Improvement in PFS was observed in most subgroups irrespective of age, gender, disease stage and prognostic factors.

Improvement in PFS was observed in most subgroups irrespective of age, gender, disease stage and prognostic factors. More patients in the group receiving ofatumumab plus chlorambucil (50%) experienced adverse events (AEs) of grade 3 or greater compared to chlorambucil alone (43%), with neutropenia being the most common adverse event (26% vs. 14%). Grade 3/4 infusion-related reactions (IRRs) were reported in 10% of patients receiving ofatumumab plus chlorambucil leading to drug withdrawal in 3% of patients and hospitalization in 2% of patients. No fatal IRRs were reported.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple has updated its Apple Maps with the release of iOS 15 to now provide new ways to explore major cities through a new 3D view. Maps users on the new iOS in London, Los Angeles, New York City, and the San Francisco Bay Area can experience a three-dimensional city view of these major cities. Deutsche Lufthansa AG has launched additional flights to the United States on short notice, aiming to tap the surging demand following the planned end of U.S. travel restrictions. The German flag carrier is also increasing domestic flights to its European hubs amid high demand. Starting in October, the company is increasing German domestic flights by 45 percent, compared with July. Gas utility Southern California Gas Co. or SoCalGas and its parent company Sempra Energy announced agreements to resolve substantially all material civil litigation related to the 2015 Aliso Canyon natural gas storage facility leak. SoCalGas, which operates the storage facility, will record an after-tax charge of approximately $1.1 billion this month.
Follow RTT